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Introduction: Rabies is a fatal acute viral disease of the central nervous system, which is a serious public health
problem in Asian and African countries. Based on the clinical presentation, rabies can be classified into encephalitic
(furious) or paralytic (numb) rabies. Early diagnosis of this disease is particularly important as rabies is invariably fatal
if adequate post exposure prophylaxis is not administered immediately following the bite.
Methods: In this study, we carried out a quantitative proteomic analysis of the human brain tissue from cases of
encephalitic and paralytic rabies along with normal human brain tissues using an 8-plex isobaric tags for relative
and absolute quantification (iTRAQ) strategy.
Results and conclusion: We identified 402 proteins, of which a number of proteins were differentially expressed
between encephalitic and paralytic rabies, including several novel proteins. The differentially expressed molecules
included karyopherin alpha 4 (KPNA4), which was overexpressed only in paralytic rabies, calcium calmodulin
dependent kinase 2 alpha (CAMK2A), which was upregulated in paralytic rabies group and glutamate ammonia
ligase (GLUL), which was overexpressed in paralytic as well as encephalitic rabies. We validated two of the
upregulated molecules, GLUL and CAMK2A, by dot blot assays and further validated CAMK2A by
immunohistochemistry. These molecules need to be further investigated in body fluids such as cerebrospinal fluid
in a larger cohort of rabies cases to determine their potential use as antemortem diagnostic biomarkers in rabies.
This is the first study to systematically profile clinical subtypes of human rabies using an iTRAQ quantitative
proteomics approach.
Keywords: Liquid chromatography, Mass spectrometry, Spectrum Mill, Hierarchical cluster, Post Exposure
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Rabies remains a significant public health challenge
worldwide with 70,000 cases reported each year with a
mortality rate of 100% in the absence of post-exposure
prophylaxis [1]. The clinical presentation of rabies en-
cephalitis in humans is in two distinct forms- the clas-
sical form which represents ~80% of all cases, also
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distribution, and reproduction in any mediumthe non-classical form which is also known as “para-
lytic” or “numb” rabies. The encephalitic form is char-
acterized by the dramatic symptom of hydrophobia,
which is a painful, violent, involuntary contraction of
the diaphragmatic, accessory respiratory, pharyngeal
and laryngeal muscles initiated by swallowing of liq-
uids. In the paralytic form of rabies, the characteristic
feature is flaccid paralysis and weakness, which often
results in misdiagnosis with diseases such as Landry/
Guillain Barre Syndrome [2-4]. Moreover, paralytic
symptoms can also be observed in post-vaccinal en-
cephalitis that occurs in some cases following adminis-
tration of Semple vaccine as post-exposure prophylaxistral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cases, the duration of survival after the onset of symp-
toms is rarely greater than 7 days [4]. Until recently,
Semple vaccination was the only mode of vaccination
in countries such as India, where rabies is relatively
common [7,8]. The onset of encephalomyelitis that oc-
curs in some patients as a post-vaccination complica-
tion is due to an inflammatory response in the host to
brain tissues contained in the Semple vaccine [9,10].
Clinical diagnosis of rabies is a challenge in the ab-
sence of specific laboratory diagnosis, and confirmation
of diagnosis is often following postmortem examination
of brain. Negri bodies are cytoplasmic inclusion bodies
within rabies infected neurons and histopathological
techniques such as Sellers staining [11] are used to
demonstrate Negri bodies. However, only 50% of the
brain samples show Negri bodies on histological evalu-
ation compared to the fluorescent antibody test for ra-
bies viral antigen, which is positive in almost 100%
cases. The specificity of Negri bodies has also been
challenged owing to the detection of inclusion bodies
indistinguishable from Negri bodies in non-rabid tis-
sues. Because of the low specificity and sensitivity,
World Health organization (WHO) no longer recom-
mends demonstration of Negri bodies for confirming a
diagnosis of rabies [12]. Other diagnostic tests include
fluorescent antibody test [13], rabies tissue culture in-
fection test (RTCIT) [14] and the mouse inoculation
test (MIT) [15], which are used for detecting viral parti-
cles. Although the fluorescent antibody test is widely
used, it requires use of brain tissue and hence can only
be performed postmortem. Some of the other available
methods such as RTCIT and MIT are time consuming
and less practical from a therapeutic perspective [12].
Thus, more sensitive methods of antemortem diagnosis
of this fatal disease is essential.
There are two major sources for discovery of protein
biomarkers - body fluids such as cerebrospinal fluid
(CSF) and serum or the primary site of disease, which
is the brain in cases of neurodegenerative diseases and
neuroinfections. Brain tissue remains a limiting factor
as the brain specimens are not obviously not accessible
for antemortem diagnosis. Although not applicable for
antemortem biomarker testing, the post-mortem brain
tissue is of use in allowing discovery of potential bio-
markers from the diseased site. As neurons in the brain
are the principal site of rabies virus infection, we se-
lected human frontal cortex as an appropriate site to
investigate such proteomic changes. Post-mortem brain
tissue has commonly been used for similar proteomic
studies in other neurological disorders [16,17].
We sought to carry out a quantitative proteomic ana-
lysis of encephalitic and paralytic rabies to identify sig-
nature proteins that are differentially regulated. Therehave been no reported studies to identify differentially
regulated proteins in human rabies. Therefore, we car-
ried out iTRAQ-based quantitative proteomics using
high resolution mass spectrometry to identify candidate
biomarkers in rabies. Using human brain tissues from
confirmed cases of encephalitic and paralytic rabies
and compared with uninfected normal brain tissues by
differential labeling with iTRAQ reagents.
The iTRAQ method has been employed to identi-
fy biomarkers in a variety of neurological disorders
[18-20]. The multiplexing capability offered by the
iTRAQ reagents, which are available as eight different
isobaric mass tags, permits simultaneous evaluation of
up to eight samples. In the current study, we used the
iTRAQ as a method to quantitatively analyze the prote-
ome of brain tissue from cases of encephalitic, paralytic
and partially vaccinated rabies, simultaneously compar-
ing with a pool of histologically normal cerebral cor-
tical tissues that serve as a common reference followed
by validation of some of the molecules using immuno-
histochemistry and dot blot assays.
Results and discussion
We carried out an iTRAQ based quantitative prote-
omic profiling of frontal cortex from confirmed cases
of rabies viral encephalitis and identified a set of mole-
cules that are differentially regulated in rabies as com-
pared to normal frontal cortex. A set of differentially
expressed proteins were identified that may serve as a
potential candidate biomarkers to differentiate enceph-
alitic from paralytic forms of rabies. The approach
employed for this study is illustrated in Figure 1.
Quantitative mass spectrometric analysis
The aim of our study was to identify differentially
expressed proteins in human brain in cases of enceph-
alitic rabies and paralytic rabies as compared to unin-
fected control human brain tissues by quantitative
proteomics. As shown in the Figure 1, we used two
technical replicates, which are lableled by two different
iTRAQ tags for each rabies group as well as control.
Quantitative proteomic analysis of rabies proteome
employing high resolution tandem mass spectrometry
coupled to liquid chromatography (LC-MS/MS) led to
59,798 MS/MS spectra from which we identified 402
proteins at 1% FDR. Additional file 1: Table S1 shows
differentially expressed proteins and the biological an-
notations associated with those proteins. Details of
combined list of peptides for proteins identified
using Spectrum Mill and Mascot are summarized in
Additional file 2: Table S2.
We identified 94 proteins as differentially regulated
in rabies as compared to normal brain tissues. In cases
of encephalitic rabies, 32 proteins were found to be
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Figure 1 Various clinical subtypes of rabies tissues were utilized to extract proteins and digested with trypsin. Peptides from four
groups including controls were labeled with iTRAQ reagents followed by LC-MS/MS on a QTOF mass spectrometer. A subset of molecules was
validated using dot blot and IHC.














































































Figure 2 Hierarchical clustering of proteins identified in rabies.
A. Hierarchical cluster of all proteins. B. Hierarchical cluster of
differentially regulated proteins in different clinical manifestations of
rabies. Protein expression intensities are represented by red and
green, for up-regulated and down-regulated fold value, respectively.
Black indicates no change in fold value and grey indicates
missing value.
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lytic rabies showed upregulation of 28 proteins and
downregulation of 11 proteins while 39 proteins were
upregulated in vaccinated rabies and 7 proteins were
downregulated.
To analyze the proteomic data from different clinical
conditions of rabies, we employed hierarchical clus-
tering analysis that allows samples which are highly
similar in quantitative profiles to be merged in an ag-
glomerative fashion using the average linkage cluster-
ing approach. Protein fold-change values as compared
to normal brain tissues were employed for this method.
We were able to distinguish encephalitic rabies from
paralytic rabies by identifying the proteome wide quan-
titative expression patterns associated with rabies. Hie-
rarchical clustering classified the human rabies samples
into two distinct groups based on their fold-changes.
As shown in the Figure 2A, paralytic samples clustered
in one branch of dendrogram because of the related-
ness of their proteome profiles while encephalitic rabies
clustered in another branch of the dendrogram indicat-
ing differences in expression pattern of proteins. The
heatmap pattern also demonstrates that, although most
of the proteins showed similar expression pattern,
proteomic differences existed between different clini-
cal subgroups of rabies patients. Figure 2B shows a
heatmap of upregulated and down regulated protein
clusters.
Functional annotation and classification of differentially
regulated proteins
Biological pathway analysis using canonical pathways
suggests a significant perturbation in the pathways such
as oxidative phosphorylation (7 proteins), tight junction
signaling (7 proteins) and calcium signaling (6 proteins)
and mitochondrial function (5 proteins). Conti et al.,
have shown that inhibition of replication of rabies
virions were correlated with inhibition of oxidative
phosphorylation cycle of the host system. This signifies
that rabies viral replication is highly energy dependent
[21]. Our proteomics study reveals upregulation of
seven proteins (ATP5L, ATP5J2, ATP6V1E1, NDUFS3,
NDUFB4, NDUFAB1 and UQCR10) involved in oxida-
tive phosphorylation. Rabies employs retrograde axonal
transport- that require energy generated through oxida-
tive phosphorylation by the involvement of several
mitochondria [22]. Hence, this process could be a
suggestive mechanism for the perturbation of path-
ways such as oxidative phosphorylation, mitochondrial
dysfunction and glycolysis. Additional file 3: Table S3
provides the functional pathways associated with rabies.
Enrichment analysis of GO terms was performed to
examine the functional distribution of the 94 differen-
tially expressed proteins using annotations in HumanProtein Reference Database (HPRD, http://www.hprd.
org) [23], which follows gene ontology (GO) standards.
Among the differentially expressed proteins, 22% of
them are involved in signal transduction, 21% of them
are associated with energy pathways and 17% of them
are involved in cell growth. Ingenuity pathway analysis
also confirmed that proteins associated with encephalitis
were enriched including astroglial marker proteins such
as GFAP [24,25], oligodendrocyte associated 2′, 3′-cyclic
nucleotide 3′ phosphodiesterase (CNP) protein [26,27]
and immunity-related GTPase family, M (IRGM1) [28].
According to ingenuity analysis, neurogenesis and guid-
ance of neurites are a few of the important physiological
functions which are enriched in our study. Enrichment
of these physiological functions is due to the differential
expression of proteins such as CTNNB1, Epsin 1 (EPN1)
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volving neuronal pathways are active in rabies infection.
Axonal morphological changes have also been observed
in the rabies infected neurons [3,29].
Proteins previously known to be associated with rabies
To the best of our knowledge, this is the first quantita-
tive proteomics study of human rabies. Dhingra et al.
have previously reported the host response in mice to
rabies virus using 2D gel analysis with MALDI-TOF
mass spectrometry and identified upregulation of pro-
teins involved in ion homeostasis such as H+ ATPase
subunit a isoform 1 and Na+/K+ ATPase [30]. Our study
also found that the human orthologs of these proteins
are upregulated in rabies. Protein Kinase C alpha
(PKCA) was found to be down regulated in rabies by
our study. PKCA regulates the nucleocytoplasmic distri-
bution of rabies phosphoprotein enabling the rabies
virus to respond to the dynamic microenvironment in
the host [31]. Our study shows that synapsin 1, a protein
localized on the cytoplasmic surface of synaptic vesicles,
is downregulated in paralytic rabies. Lewis et al. have
shown that synapsin 1 co-localizes with rabies virus in
neuromuscular junctions [32]. Tsiang and coworkers
have shown the inhibitory effects exerted by rabies vi-
rions in actin bundling by Synapsin 1. Microtubule-
associated protein 2 (MAP-2) was found to be
upregulated in encephalitic rabies. Li et al. has shown
that, pathogenic rabies N2C virus infected neurons
exhibited decreased MAP-2 staining in contrast to the
attenuated SN-10 rabies virus [33]. Thanomsridetchai
et al. analyzed the proteome of paralytic and furious
form of rabies with different anatomical areas of dog
brain which demonstrated a noticeable change in prote-
ome profiles between paralytic and furious rabies [34].
Novel upregulated proteins identified in rabies
We identified upregulation of 94 proteins in the frontal
cerebral cortex of rabies tissues in comparison to the nor-
mal human brain tissues. Subsets of the novel proteins,
which are differentially expressed, are listed in Table 1.
Figure 3 depicts annotated MS/MS spectra of selected
proteins, some of which are described below. These pro-
teins include Proteolipid protein 1 (PLP1), which is a
transmembrane protein found to be upregulated more
than 2-fold in our study. PLP1 is a predominant myelin
protein associated with axonal survival. Figure 3C pro-
vides annotated spectra for PLP1. Glutamate ammonia lig-
ase (GLUL) is mainly synthesized by astrocytes. GLUL is
shown to be associated with schizophrenia [35] moreover,
studies in simian immunodeficiency virus infected ma-
caque have also shown dense perineuronal GLUL accu-
mulation thus indicating their role in the host response to
viral infection [36]. Moreover, GLUL was also shownneuronal expression in diseases such as Alzheimer’s dis-
ease [37]. A representative MS/MS spectrum of GLUL has
been provided in Figure 3D. Calcium calmodulin
dependent kinase 2 alpha (CAMK2A) is a predominant
isoform of Calcium/calmodulin-dependent protein kinase
II, a Ca2+-activated enzyme abundant in the brain [38].
CAMK2A is 2-fold upregulated in paralytic group com-
pared to other groups in the present study. CAMK2A is
also known to be upregulated in peripheral axons after
48 h of inflammation [39]. Increased expression of
CAMK2A is also observed in frontal cerebral cortex of
cases of schizophrenia [40]. Functionally, CAMK2 is also
shown to be expressed in astrocytes and protect the cells
from apoptotic stimuli by Fas agonist [41].
Our study also identified differentially regulated pro-
teins that are associated with retrograde transport
(Importin 5) and oxidative stress (Superoxide dismu-
tase 2). Rabies also traverse by retrograde axonal trans-
port. Proteomic analyses of BHK-21 cells infected by
rabies virus has shown SOD upregulation suggesting
host cells protective mechanism against rabies infection
[42]. Apoptosis associated proteins forms a major
subset of differentially expressed proteins. These pro-
teins include phosphoprotein enriched in astrocytes 15
(PEA15), Optic atrophy 1 (OPA1), Catenin beta 1
(CTNNB1), Heat shock 70 kDa protein 5 (HSPA5) and
Heat shock 70 kDa protein 9 (HSPA9) [43-48].
Moreover, a subset of novel proteins are found to be
differentially regulated either in encephalitic rabies or
in paralytic rabies, which includes optic atrophy 1
(OPA1), limbic system associated membrane protein
(LASMP), hippocalcin-like protein 4 (HPCAL4) and
transgelin 3 (TAGLN3). The quantitative differences of
the proteome of rabies groups have shown in the
Figure 2.
Novel downregulated proteins identified in rabies
We identified several novel proteins that were
downregulated in rabies including adaptor-related protein
complex 3, beta 2 subunit (AP3B2), a vesicle coat protein,
which is 2.5-fold downregulated in rabies as compared to
normal brain. AP3B2 is component of neuron specific
AP3 complex. Clinical reports have shown that the
downregulation of PDHB presented with neurological dys-
function and high lactate concentration in CSF [49]. Pro-
grammed cell death 6 interacting protein (PDCD6IP) also
known as Alix is 2-fold downregulated in paralytic as well
as vaccinated rabies compared to normal. Functionally, it
has been shown that Alix induces apoptosis of neurons by
caspase dependent and caspase independent manner be-
sides playing a role in endosomal trafficking [50]. In con-
junction, immunohistochemical labeling of Alix has
shown an over expression in the cell body of dying neu-
rons from the lateral striatum of Lewis rats that were










1. Contactin 1 CNTN1 Over expressed in glioblastoma and localized to the surface




(ubiquinone) Fe-S protein 3
NDUFS3 NDUFS3 has upregulated in cerebral cortex while
decreased in synaptosomal complex as shown by the
quantitative proteomic study in animal models of
schizophrenia
2.1 1.6 2.6
3. Syntaxin 1A STX1A Gene expression studies have shown that high functioning
autism patients has increased expression of STX1A




NDUFAB1 An acyl carrier protein, which is a part of complex I
encoded by mitochondrial DNA. Clinical spectrum of
deficiency of complex I include muscle weakness.
2.4 2 3.7
5. Tumor protein D52 TPD52 Calcium/calmodulin-dependent protein kinase mediated
phosphorylation of TPD2 showed in rat brain studies.
1.4 2.8 2.4
6. Calcium/calmodulin-
dependent protein kinase IIA
CAMK2A It is a calcium dependent serine/threonine kinase. It is
required for hippocampal long-term potentiation (LTP) and
spatial learning. It is critical in opioid-induced hyperalgesia
1.6 2.1 4.3
7. Mitochondrial carrier homolog
2
MTCH2 Conditional knock out of MTCH2 has shown decreased Fas-
induced apoptosis, possibly by preventing tBID recruitment
to mitochondria.
2.7 - -
8. Glutamate-ammonia ligase GLUL Microarray studies has shown that altered expression of
GLUL in major depressive disorder.
4.85 2.66 5.48
9. Aldehyde dehydrogenase 2
family (mitochondrial)
ALDH2 Proteomic profiling of human anterior cingulate cortex
from patients with schizophrenia has shown differential
expression of ALDH2.
1.9 2.2 2.3
10 Growth associated protein 43 GAP43 A marker for neuronal regeneration, shown decreased
expression in hilus and inner molecular layer of
hippocampal formation from patients with schizophrenia.
4.3 2.1 2.6
11 KPNA4 KPN4 plays an important role in the nuclear import of
viruses such as HIV-1.
3.1 7.3
12 Karyopherin alpha 4 IPO5 West Nile Virus enters the nucleus by importin mediated
pathway.
2.9 1.9 1.9
13 Importin 5 PSMA2 Transcriptomic and proteomic analysis has shown
differential expression of PSMA2 in response to enterovirus
71 in rabdomyosarcoma cells.
3.1 2.6 2.5
14 Optic atrophy 1 isoform 2 OPA1 Shotgun mass spectrometry study on dorsolateral
prefrontal cortex from patients with schizophrenia has
shown differential expression of OPA1.
5.1 1.5 1.2
15 Guanine nucleotide binding
protein, alpha activating
activity polypeptide O
GNAO1 GNAO1 functions as a switch in G-protein coupling. 2.2 1.6 2.3
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corroborate with previous studies [30] which demonstrates
that rabies results in perturbation of host proteins leading
to the neuronal dysfunction. Thus, further studies are ne-
cessary to elucidate the functional importance of these in
host pathogen relations.
CAMK2A validation by immunohistochemistry
We selected candidate proteins for further validation
based on the extent of overexpression, biological import-
ance and available literature that validated their detectionin body fluids such as CSF. Differential expression of
CAMK2A has been observed in CSF samples in neuro-
logical disorders using mass spectrometry based assays
such as multiple reaction monitoring (MRM) [52]. Thus,
validation of CAMK2A overexpression in the brain tis-
sues could potentially benefit from further testing and
evaluation of CAMK2A in the CSF.
Evaluation of the histological sections helps to iden-
tify the pattern of expression and localization in differ-
ent brain cells such as neurons and astrocytes apart




Figure 3 MS/MS spectra from representative differentially regulated proteins identified in this study. The inset shows the reporter ions
used for quantitation. A. Vacuolar H + ATPase E1 isoform b (ATP6V1E1). B. Histone H2A type 3 (HIST3H2A). C. Proteolipid protein 1 (PLP1)
D. Glutamate synthetase (GLUL). E. Calcium/calmodulin-dependent protein kinase IIA (CAMK2A). Immonium ions for leucine (Imm.L) and proline
(Imm.P) are also labeled.
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on its functional relevance in neuronal signaling and 2
fold over expressed in paralytic rabies. CAMK2A ex-
pression in normal cases was seen to label in a diffuse
manner (Figure 4A). In contrast, in encephalitic rabies,
CAMK2A was seen to show intense labeling. Within
the hippocampal pyramidal neurons as well as in the
granule neurons of the dentate gyrus, CAMK2A was
seen to localize as large aggregates in the cytoplasm
(Figure 4B). These aggregates appeared to co-localize
within intracytoplasmic Negri bodies seen within these
neurons on routine hematoxylin eosin stains (Figure 4B,
inset) and as aggregates of rabies viral nucleocapsid on
immunohistochemistry. In cases of paralytic rabies, the
intensity of labeling with CAMK2A was higher com-
pared to encephalitic rabies. It was seen within hippo-
campal pyramidal neurons, aggregating as coarse
granular or clump-like fashion in addition to diffuse la-
beling of the cytoplasm and neuropil, corresponding to
localization of rabies viral antigen (Figure 4C, D). This
was more intense in vaccinated cases of paralytic ra-
bies (Figure 4D) compared to non-vaccinated cases
(Figure 4C) though localization to sites of rabies viral
accumulation within neurons was similar in both forms.CAMK2A and GLUL protein validation by dot blot assays
Immuno dot blot in Figure 5 shows a variable expression
of CAMK2A and GLUL proteins with highest expression
of CAMK2A in paralytic vaccinated form of rabies in
contrast to encephalitic and non-vaccinated paralytic
form. GLUL shows high expression in encephalitic and
paralytic (non-vaccinated) with relatively low expression
in vaccinated paralytic rabies cases. Detection of GLUL
reported in CSF makes it another potential candidate as
a diagnostic biomarker [53].
Conclusions
The diagnosis of rabies in clinical settings is based on
symptomatology. We carried out quantitative proteomics
approach employing 8-plex iTRAQ and identified 402
proteins associated with human rabies. To the best of
our knowledge, this is the first proteomics study of hu-
man rabies where we have identified 39 proteins as dif-
ferentially regulated in encephalitic rabies, 46 proteins in
vaccinated paralytic rabies and 39 proteins in paralytic
rabies. Many of these proteins are common among the
clinical manifestations of rabies. Validation of potential
candidate biomarkers like GLUL, CAMK2A and PDC
D6IP by employing Immunohistochemistry, Enzyme-
Figure 4 Immunohistochemical validation for CAMK2A on human cerebral cortex. A: Normal cortex showing labeling of soma of pyramidal
neurons extending along the apical dendrite with diffuse but light synaptic pattern of labeling of the neuropil. B: Encephalitic rabies.
Hippocampal pyramidal neurons from a case of encephalitic rabies reveal presence of CAMK2A as clumps in the cytoplasm appearing to localize
within intracytoplasmic negri bodies (proteomics: 1.6 fold elevation). Inset shows characteristic intracytoplasmic eosinophilic Negri bodies
diagnostic of rabies (arrows). C, D: Paralytic rabies. In cases of paralytic rabies, labeling with CMAK2A was seen within hippocampal pyramidal
neurons, aggregating as coarse granular or clump-like fashion in addition to diffuse labeling of the cytoplasm and neuropil, corresponding to
localization of rabies viral antigen (Inset, arrows). This was more intense in vaccinated cases of paralytic rabies (D) compared to non vaccinated
cases (C) (proteomics: 2.08 fold elevation in non vaccinated form, 4.6 fold elevation in vaccinated rabies). [A: ImmunoperoxidasexObj.20,
B: xObj.40, B, inset: H&ExObj.40B, C: Obj.x20, C, inset: Immunoperoxidase to rabies viral antigenxObj.40, D: xObj.20].
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tion monitoring (MRM) by mass spectrometry in cere-
brospinal fluid or serum will evaluate the effectiveness of




Human brain tissue samples were archived as frozen
as well as formalin fixed tissues from autopsy con-
firmed cases of encephalitic or paralytic rabies and
normal brain tissues in the Human Brain TissueRepository (Human Brain Bank), Department of
Neuropathology, National Institute of Mental Health
and Neurosciences, Bangalore, India. The study was
approved by the Institutional Ethics Review committee
of National Institute of Mental Health and Neurosci-
ences, Bangalore with informed consent of close rela-
tives of the deceased. Frozen brain tissue samples
were collected from the right frontal cortex from two
cases each of encephalitic or paralytic rabies (partially
vaccinated or non-vaccinated) and normal controls. All








Figure 5 Dot blot analysis. Immuno dot blot shows variable
expression of CAMK2A and GLUL protein with highest expression of
CAMK2A in paralytic vaccinated form of rabies in contrast to
encephalitic and non-vaccinated paralytic form. GLUL shows high
expression in encephalitic and paralytic (non-vaccinated) with
relatively low expression in vaccinated paralytic rabies cases. Blots
were run in triplicate as shown in the figure.
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firmation using immunofluorescence tests for rabies nu-
cleoprotein. The control brain tissues considered for the
study were confirmed to be negative for rabies or any
other infections. Two cases each of encephalitic, para-
lytic and partially vaccinated rabies were selected for
iTRAQ analysis. Encephalitic cases presented in the
clinic with predominant limbic symptoms, hydrophobia,
aerophobia and phobic or inspiratory spasms. These pa-
tients were tested positive by immunofluorescence test
for rabies on fresh brain tissues collected postmortem.
Patients who presented with paralytic rabies had under-
gone various neurological investigations including CSF
analysis, imaging, and electrophysiological finding to
rule out disorders such as Guillain-Barre syndrome. Two
of the cases received partial vaccination with Semple’svaccine with 2 and 6 doses respectively as part of post-
exposure prophylaxis. The immunization schedule was
incomplete, and no passive immunoglobulin was admin-
istered at the site of the bite.
All cases considered for the study were confirmed
histopathologically to have characteristic intracytoplas-
mic Negri bodies within cerebellar Purkinge neurons and
pyramidal neurons of the hippocampus, frontal and tem-
poral cortex. Widespread presence of rabies viral antigen
within various neuroanatomical regions of the brain,
most prominently in limbic areas of hippocampus, tem-
poral cortex, cingulate gyrus, orbitofrontal and insular
cortex as well as hypothalamus, brain stem and cerebel-
lum, was detected using antibodies to nucleocapsid anti-
gen of rabies virus by indirect immunoeproxidase
technique. The demographic and clinical details are pro-
vided in Table 2.
Four micron thick paraffin sections from formalin fixed
and paraffin embedded frontal cortex from the same cases
that were subjected to proteomic analysis (encephalitic,
paralytic and vaccinated and control) along with an add-
itional four paralytic cases (non-vaccinated) were used to
validate the expression pattern of some of the candidate
biomarkers identified by immunohistochemistry.iTRAQ labeling and SCX fractionation
The frontal cortical tissues were homogenized in 0.5%
SDS in a Dounce homogenizer followed by sonication.
iTRAQ (Applied Biosystems) labeling was carried out
according to manufacturer’s instructions. Briefly, 100 μg
protein of protein lysate from normal or rabies infected
tissue samples of encephalitic, paralytic and vaccinated
rabies samples were treated with a reducing agent tris
(2-carboxyethyl) phosphine (TCEP) at 60°C for 1 h and
alkylated with a cysteine blocking reagent, methyl metha-
nethiosulfonate (MMTS) for 10 min at room tem-
perature. Samples were digested with sequencing grade
trypsin (Promega) (1:20) for 16 h at 37°C. Sample digests
were further processed by labeling the normal brain-
derived peptides with iTRAQ labels of 113 and 114, en-
cephalitic rabies-derived peptides with 115 and 116,
paralytic rabies-derived peptides with 117 and 118, and
vaccinated rabies-derived peptides with 119 and 121,
thus providing technical replicates within a single run.
The iTRAQ labeled peptides pooled and fractionated by
strong cation exchange chromatography (SCX) on
PolySULFOETHYL A column (PolyLC, Columbia, MD)
(100 × 2.1 mm, 5 μm particles with 300 Å pores) using an
Agilent 1100 series LC system. Sixty SCX fractions were
collected using a 0-100% gradient of 350 mM KCl
containing 10 mM potassium phosphate buffer (pH 2.85)
and 25% acetonitrile for 70 min at a constant flow rate of
0.25 mL/min. The fractions were dried, desalted using
Table 2 Clinical and iTRAQ labeling details of the samples employed for quantitative proteomic profiling
Sample ID Age/Sex Diagnosis iTRAQ labels Post Exposure Prophylaxis Information of Dog bite
1. 06/B167 45/M Normal 113 Nil Nil
2. 06/B172 35/M Normal 114 Nil Nil
3. A29/02 11/M Non-vaccinated encephalitic rabies 115 Nil Nil
4. A5/08 28/M Non-vaccinated encephalitic rabies 116 Nil 1 month before death
5. A8/04 70/M Non-vaccinated paralytic rabies 117 Nil 2.5 month before death
6. A61/03 35/M Non-vaccinated paralytic rabies 118 Nil 2 yrs before death
7 A86/03 30/M Vaccinated rabies 119 Vaccinated 2 months before death
8 A31/08 28/M Vaccinated rabies 121 Vaccinated Right thumb, 20 days
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acid before mass spectrometric analysis.LC-MS/MS analysis
Desalted iTRAQ labeled peptides were analyzed on a
nanoflow LC-MS system containing a chip cube
interfaced with Agilent’s 6520 Accurate Mass quadrupole
time-of-flight (Q-TOF) mass spectrometer (Agilent
Technologies). The chip LC consisted of a 40 nl enrich-
ment column (75 μm× 11 mm) and a 75 μm× 150 mm
analytical column made up of Zorbax 300SB C18 5 μm.
In reversed phase liquid chromatography (RP-LC), mo-
bile phase A consisted of 0.1% (v/v) formic acid in water,
and mobile phase B was 0.1% (v/v) formic acid in 90%
acetonitrile. The separation was performed with a linear
gradient of B (3% to 40% v/v), at a constant flow rate of
400 nl/min. The ESI source operated in positive mode.
Data- dependent acquisition was carried out using
MassHunter software with precursor survey scan
for 1 second (from 350–1,800 m/z) followed by three
MS/MS scans.Data analysis
The mass spectrometry data was searched using
Spectrum Mill (Agilent Technologies, Version A.03.03)
and Mascot (Matrix Science Inc., Version 2.2.0) against
human RefSeq Build 35 protein sequence database. Hu-
man RefSeq Build 26 (~30,000 protein entries) was used
for data search in Spectrum Mill. Searches were carried
out with the following search criteria, oxidation of me-
thionine, iTRAQ-8-plex (N-term) and iTRAQ-8plex (K)
were selected as fixed modifications and methyl thio-
cysteine as a fixed modification. In Mascot as well as
Spectrum Mill searches, MS tolerance was set to
100 ppm and MS/MS mass tolerance of 0.1 Da. Only
one missed cleavage was allowed. False discovery rate
(FDR) was calculated by searching the data against the
corresponding reverse database. Peptides with 1% FDR
were used to identify proteins. Proteins identified with
only one peptide identification from Spectrum Mill orMascot was further validated by manual inspection of
MS/MS spectra.Quantitation and statistical analysis
Protein quantitation was carried out using Spectrum
Mill and Mascot Distiller (Version 2.3.1.0). Peptides
with missing reporter ions were not considered for the
calculation of reporter ion ratios. Average intensities of
the technical replicates were calculated. Intensity of re-
porter ions 113 and 114, which corresponds to normal
frontal cortex were employed to calculate the fold-
changes of proteins against encephalitic rabies (reporter
ions 115 and 116), paralytic rabies (reporter ions 117
and 118) and vaccinated rabies (reporter ions 119 and
121) [54]. To improve the visualization of quantitation,
we created a hierarchical cluster of proteins identified in
rabies infected brain. Proteins, which had a fold-change
values of >2-fold were considered as differentially regu-
lated. Hierarchical clustering of differentially regulated
proteins was carried out by log base 2 transformations
of fold ratios followed by normalization across the sam-
ples as provided in MeV. Euclidian distance was used as
distance metric and complete linkage employed as link-
age method for hierarchical clustering by MeV [55].Functional analysis
We employed Ingenuity Pathways Analysis (IPA) soft-
ware version 7.1 (Ingenuity Systems, Mountain View,
CA, USA) for functional analysis. We uploaded proteins
which were identified as differentially regulated in rabies
as well as their corresponding fold changes. IPA soft-
ware was employed to compare the data from different
clinical manifestations of rabies using single group com-
parison of IPA, which allows a comparison of different
subjects from the same group. Functional annotations
and canonical pathways were identified with using a
threshold p-value of 0.01 after Fishers exact test. We
have annotated localization, biological process and func-
tional class of proteins by mapping gi accession num-
bers to HPRD accession numbers [56].
Venugopal et al. Clinical Proteomics 2013, 10:3 Page 11 of 13
http://www.clinicalproteomicsjournal.com/content/10/1/3Antibodies
Dot blot was carried out using commercially available
antibodies, which were procured from Abcam,
Cambridge, MA and directed against GLUL at 1:1000
dilution and CAMK2A at 1:100 dilution were carried
out on one case of each group as triplicates. In addition,
we also carried out immunohistochemical labeling for
CAMK2A at 1:100 dilution from paraffin-embedded
sections from the frontal cortex and hippocampus of
ten cases of rabies {8 paralytic rabies (2 vaccinated ra-
bies and 6 non-vaccinated rabies), 2 encephalitic rabies}
and 4 normal controls.
Immunohistochemical labeling
The molecules selected for validation were based on the
biological relevance and their potential to secretory na-
ture and/or presence of transmembrane domain. We
chose CAMK2A in order to validate their potential to
act as candidate biomarker. To visualise the immune re-
action, Envision kit (DAKO) was used according to the
manufacturer’s instructions. Briefly, tissue sections were
deparaffinised and antigen retrieval was carried out in
citrate buffer (pH 6) by microwaving the tissue sections
for 30 minutes. Endogenous peroxidase were quenched
by 3% of hydrogen peroxide solution and washed in
wash buffer (0.1% Tween in PBS). Sections were incu-
bated overnight with the primary antibodies. After rins-
ing in wash buffer, the slides were incubated with HRP
conjugated appropriate secondary antibody. The signal
was developed using Dako chromogen (DAB/Hydrogen
peroxidase). The sections were counterstained with
Harris’ hematoxylin (blue nuclear stain). The immuno-
histochemical labeling was assessed by two experienced
neuropathologists (AM, SKS) and the findings are sum-
marized in the results section.
Dot blot assays
For dot blot analyses, 12 μg of protein from each brain
tissue lysates were spotted in triplicate onto nitrocellu-
lose membranes, blocked with 2% milk in PBS-T for one
hour and then incubated with protein (CAMK2A, GLUL
and ACTB) specific primary antibodies for 90 minutes at
room temperature. The membranes were washed with
PBS-T and incubated with HRP conjugated anti-rabbit
secondary antibody – 1:5000 dilution for 90 minutes at
room temperature. Secondary antibody treated blots
were washed thrice with PBS-T. Protein detection was
carried out using DAB based detection system.
Data availability
Quantitative proteomics data derived from rabies study
were submitted to Human Proteinpedia, to make it
available for the public [57]. This includes the details of
study design, experimental methods, peptides andproteins identified. The entire rabies data could be
downloaded from Tranche data repository. This could be
performed using Data set (1) "S/BvVTpUE09k0gN
OjAP6lbQKxiAzpsd/f92Lu0KfU61PzoxnbGPiS9Hn5EqL3B
hAl9HD2 + LReVGAGnoI9QSTFDkaJfAAAAAAABGKwg





Additional file 1: Table S1. Differentially expressed proteins identified
in rabies. Description of data: List of 94 proteins that are differentially
expressed in rabies compared to normal brain tissues.
Additional file 2: Table S2. Combined list of peptides for proteins
identified using Spectrum Mill and Mascot. Description of data: A list of
402 peptides and their fold changes compared to normal are
summarized in Additional file 2: Table S2.
Additional file 3: Table S3. Functional analysis of the proteins by
ingenuity pathway analysis. Description of data: Additional file 3: Table S3
provides functional annotations of identified proteins as well as
p-value with FDR correction.
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